According to the current oilahuasca theory CYP2C9 creates 3'-hydroxysafrole, 1'-hydroxysafrole and 2'-hydroxysafrole in vivo from safrole by the actions of CYP2C9. The theory states that of these three safrole metabolites 3'-hydroxysafrole is a necessary intermediate step in achieving psychedelic activity from safrole.
Common alternate names for these thee alkaloids are Safrole I, Safrole II, and Safrole III respectively.
The oilahuasca theory states that one or more of these alkaloid metabolites can produce psychedelic activity in man.
Note that these three alkaloid metabolites are proven to form in vivo from safrole, but exactly how they form is currently theoretical.
PubChem Compound ID: 149743
Molecular Weight: 178.1846 [g/mol]
Molecular Formula: C10H10O3
IUPAC Name: 3-(1,3-benzodioxol-5-yl)prop-1-en-1-ol
Canonical SMILES: C1OC2=C(O1)C=C(C=C2)CC=CO